secwatch.observer — SEC 8-K summary
======================================

Issuer:     Scholar Rock Holding Corp (SRRK)
CIK:        0001727196
Form:       8-K
Filed at:   2022-11-09T23:59:59+00:00
Accession:  0001157523-22-001571
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Scholar Rock appoints Dr. Jing Marantz as CMO, grants 250,000-share option award
--------------------------------------------------------------------------------

- Dr. Jing Marantz appointed CMO effective Nov 9, 2022; brings >20 yrs experience in neurology, oncology, rare diseases.
- Base salary $465,000, annual bonus target 40% of base, and inducement stock option for 250,000 shares.
- Option vests 25% on first anniversary, remainder quarterly over 3 years; subject to continuing service.
- Prior roles include EVP/CBO at Krystal Biotech, SVP at Acceleron (Merck) and Alnylam; board member at Arcturus Therapeutics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1727196/000115752322001571/0001157523-22-001571-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1727196/000115752322001571/a52964704.htm
  HTML page:      https://secwatch.observer/filing/0001157523-22-001571

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer